NRX Pharmaceuticals, Inc. Quarterly Interest Expense in USD from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
NRX Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2020 to Q1 2024.
  • NRX Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $230K.
  • NRX Pharmaceuticals, Inc. annual Interest Expense for 2023 was $120K.
  • NRX Pharmaceuticals, Inc. annual Interest Expense for 2021 was $18K, a 67.9% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $230K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q3 2023 $40K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q1 2022 $16K $3K -$2K -40% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $18K $3K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $5K -$7.51K -60% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $5K +$2.47K +97.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $5K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $12.5K Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-08-12
Q2 2020 $2.53K Apr 1, 2020 Jun 30, 2020 10-Q/A 2022-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.